Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dashyant Dhanak

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
ACS Medicinal Chemistry Letters|June 6, 2014
Cracking the code: the promise of epigeneticsDashyant Dhanak
Nature|October 25, 2013
Chromatin proteins and modifications as drug targetsKristian Helin, Dashyant Dhanak
Biochemical and Biophysical Research Communications|July 13, 2014
Development and classes of epigenetic drugs for cancerDashyant Dhanak, Paul Jackson
Trends in Pharmacological Sciences|April 23, 2004
From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal functionStephen A Douglas, Dashyant Dhanak, Douglas G Johns
Cell Chemical Biology|September 23, 2017
Small-Molecule Targets in Immuno-OncologyDashyant Dhanak, James P Edwards, Ancho Nguyen, et al.
Journal of Molecular and Cellular Cardiology|June 27, 2006
Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligationNicolas Bousette, Fu Hu, Eliot H Ohlstein, et al.
Journal of Molecular and Cellular Cardiology|September 21, 2005
A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blockerEwa Rakowski, Ghada S Hassan, Dashyant Dhanak, et al.
Peptides|August 22, 2006
Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart diseaseNicolas Bousette, Julia Pottinger, Wisam Ramli, et al.
British Journal of Pharmacology|October 3, 2002
Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonistDavid J Behm, Christopher L Herold, Eliot H Ohlstein, et al.
Biochemistry|December 1, 2004
Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibitionLusong Luo, Jeffrey D Carson, Dashyant Dhanak, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
ACS Medicinal Chemistry Letters|June 6, 2014
Cracking the code: the promise of epigeneticsDashyant Dhanak
Nature|October 25, 2013
Chromatin proteins and modifications as drug targetsKristian Helin, Dashyant Dhanak
Biochemical and Biophysical Research Communications|July 13, 2014
Development and classes of epigenetic drugs for cancerDashyant Dhanak, Paul Jackson
Trends in Pharmacological Sciences|April 23, 2004
From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal functionStephen A Douglas, Dashyant Dhanak, Douglas G Johns
Cell Chemical Biology|September 23, 2017
Small-Molecule Targets in Immuno-OncologyDashyant Dhanak, James P Edwards, Ancho Nguyen, et al.
Journal of Molecular and Cellular Cardiology|June 27, 2006
Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligationNicolas Bousette, Fu Hu, Eliot H Ohlstein, et al.
Journal of Molecular and Cellular Cardiology|September 21, 2005
A role for urotensin II in restenosis following balloon angioplasty: use of a selective UT receptor blockerEwa Rakowski, Ghada S Hassan, Dashyant Dhanak, et al.
Peptides|August 22, 2006
Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart diseaseNicolas Bousette, Julia Pottinger, Wisam Ramli, et al.
British Journal of Pharmacology|October 3, 2002
Pharmacological characterization of SB-710411 (Cpa-c[D-Cys-Pal-D-Trp-Lys-Val-Cys]-Cpa-amide), a novel peptidic urotensin-II receptor antagonistDavid J Behm, Christopher L Herold, Eliot H Ohlstein, et al.
Biochemistry|December 1, 2004
Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibitionLusong Luo, Jeffrey D Carson, Dashyant Dhanak, et al.
Pageof 5